Convergent Evolution of Escape from Hepaciviral Antagonism in Primates
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The ability to mount an interferon response on sensing viral infection is a critical component of mammalian innate immunity. Several viruses directly antagonize viral sensing pathways to block activation of the host immune response. Here, we show that recurrent viral antagonism has shaped the evolution of the host protein MAVS--a crucial component of the viral-sensing pathway in primates. From sequencing and phylogenetic analyses of MAVS from 21 simian primates, we found that MAVS has evolved under strong positive selection. We focused on how this positive selection has shaped MAVS' susceptibility to Hepatitis C virus (HCV). We functionally tested MAVS proteins from diverse primate species for their ability to resist antagonism by HCV, which uses its protease NS3/4A to cleave human MAVS. We found that MAVS from multiple primates are resistant to inhibition by the HCV protease. This resistance maps to single changes within the protease cleavage site in MAVS, which protect MAVS from getting cleaved by the HCV protease. Remarkably, most of these changes have been independently acquired at a single residue 506 that evolved under positive selection. We show that "escape" mutations lower affinity of the NS3 protease for MAVS and allow it to better restrict HCV replication. We further show that NS3 proteases from all other primate hepaciviruses, including the highly divergent GBV-A and GBV-C viruses, are functionally similar to HCV. We conclude that convergent evolution at residue 506 in multiple primates has resulted in escape from antagonism by hepaciviruses. Our study provides a model whereby insights into the ancient history of viral infections in primates can be gained using extant host and virus genes. Our analyses also provide a means by which primates might clear infections by extant hepaciviruses like HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 MAVS has evolved under positive selection in primates. (A) dN/dS ratios for the MAVS gene, calculated using free-ratio model in PAML, are shown on a phylogeny [26] along with common and scientific names of the primate species represented. Branches with dN/dS ratios greater than 1 are highlighted in red. For branches that did not experience any synonymous (S) changes, number of nonsynonymous (N) and S changes are shown in parentheses. (B) Residues identified as being under recurrent positive selection are indicated on a schematic of the MAVS protein, including the CARD, Proline-rich, and transmembrane (TM) domains. CodeML program of PAML software was used to identify sites under positive selection by comparing M7 (beta) versus M8 (beta & ω) models, assuming codon frequencies according to the F61 model. Web-based implementation of HyPhy package was used to perform REL analysis. We present only those sites identified with a posterior probability higher than 0.9 in both Bayes empirical Bayes (BEB) and random effects likelihood (REL) methods.](https://figures.cochat.ai/paper-figures/a92e7577dd1343f8a439fc331bfa2462/convergent-evolution-of-escape-from-hepaciviral-antagonism-in-primates-figure-1.jpg)



![Figure 5 NS3 proteases from distantly related GB viruses inhibit human MAVS. (A) Phylogram made using NS3 sequence from the indicated viruses. Bootstrap values are indicated for each branch. Scale represents 0.1 amino acid substitutions per site. Bovine viral diarrheal virus (BVDV) and Yellow fever virus (YFV) are representative pesti- and flaviviruses, respectively. We refer to GBV-C and GBV-A viruses as hepaciviruses, although they have not been formally assigned to a particular genus within the Flaviviridae family. GBV-C is also known as Hepatitis G virus (HGV). CHV stands for canine hepacivirus [17]. Corresponding hosts that can be naturally infected by each virus are indicated on the right. (B) IFN-β induction, as determined by luciferase firefly activity upon expression of human MAVS in the presence of NS3 protease from the corresponding virus in (A). IFN-β induction is normalized as being 100% in absence of any protease. Experiments were performed in triplicate with error bars indicating standard deviation.](https://figures.cochat.ai/paper-figures/7ee3f99151af48d6be3a639ae7eb297b/convergent-evolution-of-escape-from-hepaciviral-antagonism-in-primates-figure-5.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several core components of the vertebrate immune system have subsequently been shown to engage in such conflicts, some of which are able to dictate the outcome of an infection 29, 30, 31, 32, 33, 34, 35.”
From Buried Treasure: Evolutionary Perspectives on Microbial Iron Piracy (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PAML 4: Phylogenetic Analysis by Maximum Likelihood
Yang, Z. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm088 · Cited by 13,879 · cited 8×
“However, using maximum-likelihood analyses [27,28], we found that MAVS has evolved under strong positive selection in primates.”
BackgroundMethodInfluentialPAML: a program package for phylogenetic analysis by maximum likelihood
Yang, Z. (1997) · Bioinformatics · doi:10.1093/bioinformatics/13.5.555 · Cited by 5,373 · cited 8×
“However, using maximum-likelihood analyses [27,28], we found that MAVS has evolved under strong positive selection in primates.”
BackgroundMethodInfluentialThe HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929 · cited 1×
“Among the myriad of antiviral mechanisms employed by mammalian cells, the ability to sense viral RNA has emerged as a critical component of innate immunity. Viral RNA is detected in the cytoplasm by sensor proteins RIG-I and MDA-5”
BackgroundGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514 · cited 1×
“Furthermore, a polymorphism near a type III interferon gene is associated with spontaneous and treatment-induced clearance of HCV [45,46].”
BackgroundSeth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562 · cited 3×
“Viral RNA is detected in the cytoplasm by sensor proteins RIG-I and MDA-5 [1–3].”
BackgroundCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401 · cited 1×
“In particular, several viruses encode antagonists of MAVS function”
BackgroundGenetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150 · cited 1×
“HCV cleaves MAVS in order to block the interferon response. The importance of this strategy employed by HCV is highlighted by the fact that interferon treatment is often clinically used to successfully cure HCV infection. Furthermore, a polymorphism near a type III interferon gene is associated with spontaneous and tr…”
BackgroundVISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853 · cited 1×
“MAVS pathway in Figure S1) [4–7].”
A molecular phylogeny of living primates
Perelman, P., Johnson, W. E., Roos, C., Seuánez, H. N., Horvath, J. E., Moreira, M. A. M., Kessing, B., Pontius, J., Roelke, M., Rumpler, Y., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001342 · Cited by 1,414 · cited 4×
“(A) dN/dS ratios for the MAVS gene, calculated using freeratio model in PAML, are shown on a phylogeny [26] along with common and scientific names of the primate species represented.”
MethodResultInfluentialMolecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent
Linnen, J., Wages, J., Zhang-Keck, Z.-Y., Fry, K. E., Krawczynski, K. Z., Alter, H., Koonin, E., Gallagher, M., Alter, M., Hadziyannis, S., et al. (1996) · Science · doi:10.1126/science.271.5248.505 · Cited by 1,359
Isolation of novel virus-like sequences associated with human hepatitis
Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M., & Mushahwar, I. K. (1995) · Nature Medicine · doi:10.1038/nm0695-564 · Cited by 1,129 · cited 1×
“These two viruses have tentatively been assigned to a new Pegivirus genus, as a sister genus to the Hepacivirus genus within the Flaviviridae family (although this designation has not yet been formally accepted by the International Committee on Taxonomy of Viruses) [37–42].”
BackgroundAndrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S., & Randall, R. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407639101 · Cited by 992 · cited 1×
“Viral RNA is detected in the cytoplasm by sensor proteins RIG-I and MDA-5 [1–3].”
BackgroundGenetic diversity and evolution of hepatitis C virus – 15 years on
Simmonds, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.80401-0 · Cited by 865 · cited 1×
“HCV is a single-stranded positive sense RNA virus that belongs to the Flaviviridae class of viruses that causes chronic liver disease and is estimated to infect 170 million people globally (about 3% of the world’s population) [14,15].”
BackgroundLi, X.-D., Sun, L., Seth, R. B., Pineda, G., & Chen, Z. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508531102 · Cited by 840 · cited 2×
“This inhibition is specific to the HCV protease-mediated proteolysis at residue 508, since introducing a C508R mutation in human MAVS blocks this inhibition, as shown previously (Figure 2A) [8].”
MethodSawyer, S. L., Wu, L. I., Emerman, M., & Malik, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409853102 · Cited by 688 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundSelf-citationKang, D.-C., Gopalkrishnan, R. V., Wu, Q., Jankowsky, E., Pyle, A. M., & Fisher, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022637199 · Cited by 651
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundSelf-citationA random effects branch-site model for detecting episodic diversifying selection
Kosakovsky Pond, S. L., Murrell, B., Fourment, M., Frost, S. D. W., Delport, W., & Scheffler, K. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr125 · Cited by 400
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
Loo, Y.-M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H., Yoneyama, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601523103 · Cited by 391 · cited 1×
“), pcDNA6-BVDVpro (kindly provided by Kui Li), pcDNA6-YFVpro (kindly provided by Kui Li), Human MAVS (C508Y) (previously described [52]), and pcDNA-Myc-sc-NS3 (S1165A) (previously described [33]).”
MethodSelf-citationDisruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320 · cited 1×
“Thus, given that paleovirology relies on the use of extant viruses as surrogates of their ancient counterparts to test the function of positively selected changes in host factors, viral ‘‘footprints’’ left by functionally constrained antagonists like proteases are particularly well suited for paleovirology [11,12].”
BackgroundMukherjee, A., Morosky, S. A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., & Coyne, C. B. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001311 · Cited by 305 · cited 4×
“For example, coxsackievirus uses its 3C protease to cleave human MAVS between residues 148 and 149 (Figure S4) [12].”
BackgroundInfluentialWang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299 · cited 4×
“HCV protein was further detected using the hyperimmune serum from an HCV-infected patient that recognizes HCV proteins NS3, NS4B, and NS5A [35].”
MethodSelf-citationMcNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J. D., & Bieniasz, P. D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000300 · Cited by 298 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundCharacterization of a canine homolog of hepatitis C virus
Kapoor, A., Simmonds, P., Gerold, G., Qaisar, N., Jain, K., Henriquez, J. A., Firth, C., Hirschberg, D. L., Rice, C. M., Shields, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101794108 · Cited by 288 · cited 2×
“Recently, HCV-like viruses have also been found in non-primate mammalian species, specifically in bats and dogs [16,17].”
BackgroundSite-to-Site Variation of Synonymous Substitution Rates
Pond, S. K., & Muse, S. V. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi232 · Cited by 274 · cited 4×
“( ) Table S1 Statistical evidence for sites evolving under positive selection in MAVS.”
BackgroundInfluentialProtein kinase R reveals an evolutionary model for defeating viral mimicry
Elde, N. C., Child, S. J., Geballe, A. P., & Malik, H. S. (2009) · Nature · doi:10.1038/nature07529 · Cited by 260 · cited 3×
“Isolation of total RNA was done as described previously [18].”
BackgroundMethodSelf-citationWang, C., Pflugheber, J., Sumpter, R., Sodora, D. L., Hui, D., Sen, G. C., & Gale, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.3898-3912.2003 · Cited by 231 · cited 4×
“HCV protein was further detected using the hyperimmune serum from an HCV-infected patient that recognizes HCV proteins NS3, NS4B, and NS5A [35].”
BackgroundSelf-citationGraef, K. M., Vreede, F. T., Lau, Y.-F., McCall, A. W., Carr, S. M., Subbarao, K., & Fodor, E. (2010) · Journal of Virology · doi:10.1128/jvi.00879-10 · Cited by 209 · cited 2×
“Consistent with this idea, all other known viral antagonists of MAVS, including proteases from other viruses, interact with different regions of MAVS [9–12].”
BackgroundSong, B., Gold, B., O'hUigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6111-6121.2005 · Cited by 199 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundPaleovirology—Modern Consequences of Ancient Viruses
Emerman, M., & Malik, H. S. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000301 · Cited by 186 · cited 1×
“We have previously proposed that virus-driven adaptive evolution of host antiviral factors can be used as a tool in paleovirology, the study of ancient viruses and their impact of host evolution [49,50].”
BackgroundSelf-citationRapid evolution of primate antiviral enzyme APOBEC3G
Zhang, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh183 · Cited by 182 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundGenomic Fossils Calibrate the Long-Term Evolution of Hepadnaviruses
Gilbert, C., & Feschotte, C. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000495 · Cited by 148 · cited 1×
“One explanation—supported by recent data from genomic viral ‘‘fossils’’ [51]—is that long-term virus evolution is much slower than expected due to functional constraint [50].”
BackgroundPhylogeny of the macaques (Cercopithecidae: Macaca) based on Alu elements
Li, J., Han, K., Xing, J., Kim, H., Rogers, J., Ryder, O. A., Disotell, T. R., Yue, B., & Batzer, M. A. (2009) · Gene · doi:10.1016/j.gene.2009.05.013 · Cited by 140
Roivainen, M., Knip, M., Hyöty, H., Kulmala, P., Hiltunen, M., Vähäsalo, P., Hovi, T., Åkerblom, H. K., & the Childhood Diabetes in Finland (DiMe) Study Group (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199809)56:1<44::aid-jmv8>3.0.co;2-n · Cited by 139 · cited 1×
“These two viruses have tentatively been assigned to a new Pegivirus genus, as a sister genus to the Hepacivirus genus within the Flaviviridae family (although this designation has not yet been formally accepted by the International Committee on Taxonomy of Viruses) [37–42].”
BackgroundPaleovirology—ghosts and gifts of viruses past
Patel, M. R., Emerman, M., & Malik, H. S. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.06.007 · Cited by 138 · cited 3×
“One explanation—supported by recent data from genomic viral ‘‘fossils’’ [51]—is that long-term virus evolution is much slower than expected due to functional constraint [50].”
BackgroundSelf-citationGB Virus B Disrupts RIG-I Signaling by NS3/4A-Mediated Cleavage of the Adaptor Protein MAVS
Chen, Z., Benureau, Y., Rijnbrand, R., Yi, J., Wang, T., Warter, L., Lanford, R. E., Weinman, S. A., Lemon, S. M., Martin, A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02076-06 · Cited by 136 · cited 1×
“Consistent with previous reports, NS3 protease from GBV-B also inhibited human MAVS, while proteases from the more distantly related pestivirus bovine viral diarrhea virus (BVDV) and flavivirus yellow fever virus (YFV) did not antagonize MAVS (Figure 5) [43].”
ResultRapid evolution of protein kinase PKR alters sensitivity to viral inhibitors
Rothenburg, S., Seo, E. J., Gibbs, J. S., Dever, T. E., & Dittmar, K. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1529 · Cited by 127 · cited 1×
“For example, adaptive changes at key residues in the antiviral gene Protein Kinase R (PKR), likely driven by ancient viruses, are important determinants of PKR’s ability to resist antagonism by present-day poxviruses [18,25].”
BackgroundIwai, A., Shiozaki, T., Kawai, T., Akira, S., Kawaoka, Y., Takada, A., Kida, H., & Miyazaki, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112458 · Cited by 125 · cited 2×
“Consistent with this idea, all other known viral antagonists of MAVS, including proteases from other viruses, interact with different regions of MAVS [9–12].”
BackgroundJohnson, C. L., Owen, D. M., & Gale, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610361200 · Cited by 92 · cited 3×
“), pcDNA6-BVDVpro (kindly provided by Kui Li), pcDNA6-YFVpro (kindly provided by Kui Li), Human MAVS (C508Y) (previously described [52]), and pcDNA-Myc-sc-NS3 (S1165A) (previously described [33]).”
MethodSelf-citationEvaluating the evidence for virus/host co-evolution
Sharp, P. M., & Peter Simmonds, K. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.018 · Cited by 89
Zhang, R., Durkin, J., Windsor, W. T., McNemar, C., Ramanathan, L., & Le, H. V. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.6208-6213.1997 · Cited by 87 · cited 1×
“Previous studies have demonstrated that this position is an important determinant of HCV polyprotein cleavage by NS3/4A protease, with valine being the preferred residue at P3 [31,32].”
BackgroundBukh, J., & Apgar, C. L. (1997) · Virology · doi:10.1006/viro.1997.8461 · Cited by 86 · cited 3×
“In contrast, hepaciviruses were assayed for but not found in spider monkeys, which have ‘‘resistant’’ MAVS [38].”
BackgroundSumpter, R., Wang, C., Foy, E. M., Loo, Y., & Gale, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11591-11604.2004 · Cited by 81 · cited 1×
“HCV Restriction Assay Huh7-K2040 is a Huh7-based human hepatocyte cell line that contains the self-replicating subgenomic replicon from HCV 1b [34].”
BackgroundSelf-citationEpstein, J. H., Quan, P., Briese, T., Street, C., Jabado, O., Conlan, S., Khan, S. A., Verdugo, D., Hossain, J., Hutchison, S. K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000972 · Cited by 75 · cited 1×
“Recently, HCV-like viruses have also been found in non-primate mammalian species, specifically in bats and dogs [16,17].”
BackgroundPaulmann, D., Magulski, T., Schwarz, R. L., Heitmann, L., Flehmig, B., Vallbracht, A., & Dotzauer, A. (2008) · Journal of General Virology · doi:10.1099/vir.0.83521-0 · Cited by 54 · cited 1×
“function [5,8–13].”
Evolutionary Trajectories of Primate Genes Involved in HIV Pathogenesis
Ortiz, M., Guex, N., Patin, E., Martin, O., Xenarios, I., Ciuffi, A., Quintana-Murci, L., & Telenti, A. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp197 · Cited by 53 · cited 1×
“Positive selection has been seen previously in many antiviral factors characterized in primate genomes [18–24].”
BackgroundDetection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus.
Adams, N. J., Lewis, J. C., McClure, M. O., Smith, D. B., Prescott, L. E., Peter Simmonds, K., & Jarvis, L. M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1871 · Cited by 43 · cited 1×
“These two viruses have tentatively been assigned to a new Pegivirus genus, as a sister genus to the Hepacivirus genus within the Flaviviridae family (although this designation has not yet been formally accepted by the International Committee on Taxonomy of Viruses) [37–42].”
BackgroundSpecies-specific variants of GB virus A in captive monkeys
Leary, T. P., Desai, S. M., Yamaguchi, J., Chalmers, M. L., Schlauder, G. G., Dawson, G. J., & Mushahwar, I. K. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.9028-9030.1996 · Cited by 40 · cited 1×
“And although its natural host is unknown, it has been shown to infect tamarins and marmosets [36,37].”
BackgroundKim, S. Y., Park, K. W., Lee, Y., Back, S. H., Goo, J. H., Park, O. K., Jang, S. K., & Park, W. J. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4662 · Cited by 34 · cited 1×
“Previous studies have demonstrated that this position is an important determinant of HCV polyprotein cleavage by NS3/4A protease, with valine being the preferred residue at P3 [31,32].”
BackgroundCharrel, R. N., de Micco, P., & de Lamballerie, X. N. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-9-2329 · Cited by 34 · cited 2×
“GBV-C viruses that infect humans and chimps are thought to have co-diverged with their ancestors 7 million years ago [47].”
BackgroundThe Marmoset Model of GB Virus B Infections: Adaptation to Host Phenotypic Variation
Weatherford, T., Chavez, D., Brasky, K. M., & Lanford, R. E. (2009) · Journal of Virology · doi:10.1128/jvi.00033-09 · Cited by 16 · cited 1×
“And although its natural host is unknown, it has been shown to infect tamarins and marmosets [36,37].”
Background
Research works printed but not linked: 1
- Fields B. N Knipe D. M Howley P. M 2007 Fields' virology Philadelphia Wolters Kluwer Health/Lippincott Williams & Wilkins 2 v. (xix, 3091, 3086 pp.)
Cited by
Decoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Rules of engagement: molecular insights from host–virus arms races
Daugherty, M. D., & Malik, H. S. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155522 · Cited by 515
Self-citationYi, C., Sun, X., Ye, J., Ding, L., Liu, M., Yang, Z., Lu, X., Zhang, Y., Ma, L., Gu, W., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0458-z · Cited by 486
Genome of the Chinese tree shrew
Fan, Y., Huang, Z.-Y., Cao, C.-C., Chen, C.-S., Chen, Y.-X., Fan, D.-D., He, J., Hou, H.-L., Hu, L., Hu, X.-T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2416 · Cited by 364
“3), in which recurrent viral antagonism has led to a convergent evolution of escape from hepaciviral antagonism in primates 42 .”
Bats are a major natural reservoir for hepaciviruses and pegiviruses
Quan, P.-L., Firth, C., Conte, J. M., Williams, S. H., Zambrana-Torrelio, C. M., Anthony, S. J., Ellison, J. A., Gilbert, A. T., Kuzmin, I. V., Niezgoda, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303037110 · Cited by 285
Metadata
- Authors
- Patel, M. R., Loo, Y.-M., Horner, S. M., Gale, M., & Malik, H. S.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Malik, Harmit S.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-13
- Volume
- 10
- Issue
- 3
- Pages
- e1001282
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC3302847
- OpenAlex
- W2120167579
- Cited by
- 95
- References
- 53
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 11 · 2014: 6 · 2013: 16 · 2012: 8
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Foundation (CAREER)
- Howard Hughes Medical Institute
- Cancer Research Institute
- National Institutes of Health (AI083019, AI88778, AI060389)
- National Cancer Institute (P30CA015704)
- National Institute of Allergy and Infectious Diseases (R01AI060389, U19AI083019, AI88778, R56AI060389, AI-060389, AI083019, U19AI088778)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- MAVS, interferon response, viral antagonism, hepatitis C virus, NS3/4A protease, hepatitis G virus, positive selection, convergent evolution, viral sensing, host-virus coevolution, proteolytic cleavage sites
- MeSH terms
- Viral Proteases, Amino Acid Sequence, Animals, Genes, Viral, Hepatitis C, Humans, Models, Molecular, Molecular Sequence Data, Phylogeny, Primates, Selection, Genetic, Serine Endopeptidases, Virus Replication, Hepacivirus, Sequence Alignment, Viral Nonstructural Proteins, Evolution, Molecular, Nucleoside-Triphosphatase, Adaptor Proteins, Signal Transducing, DEAD-box RNA Helicases, Host-Pathogen Interactions, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.